Of all the 27 human TRP channel genes examined, TRPV2 shows the highest expression in endometrial carcinoma [40], where elevated TRPV2 mRNA expression heralds an adverse outcome [215,216]. This evidence concerns the gene TRPV2 and endometrial carcinoma.